| Serial Number | 79339791 |
| Word Mark | OPTIMER |
| Filing Date | Tuesday, June 29, 2021 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, September 10, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, September 10, 2024 |
| Description of Mark | The mark consists of the word "OPTIMER" in a stylized font. |
| Goods and Services | Reagents for medical use; chemical reagents for medical use; medical, veterinary, clinical, diagnostic and pharmaceutical reagents, agents, chemicals, materials, substances and preparations, namely, clinical medical reagents, reagents for medical use, veterinary diagnostic reagents, chemical reagents for medical purposes, diagnostic agents, preparations and substances for medical purposes; optimised aptamer molecules for medical and veterinary use, namely, veterinary diagnostic reagents, chemical reagents for medical purposes, diagnostic media for bacteriological cultures; medical and veterinary diagnostic reagents and assays for testing of body fluids; medical and veterinary diagnostic test strips for the analysis of blood, urine, saliva, human tissue and animal tissue; diagnostic biomarker reagents for medical and veterinary purposes; reagents and media for medical and veterinary diagnostic or treatment purposes, namely, diagnostic reagents and contrast media for medical use; nucleic acids for medical, veterinary, diagnostic and pharmaceutical purposes, namely, nucleic acids being diagnostic reagents and chemical reagents for medical and veterinary purposes; nucleic acid sequences for medical, veterinary, diagnostic and pharmaceutical purposes; diagnostic testing kits comprised of medical diagnostic reagents, assays, monoclonal antibodies, buffers and reagents for testing of bodily fluids, human tissue and animal tissue for use in disease detection; diagnostic reagents for medical and veterinary use for sale in kit form; diagnostic kits comprising specimen receptors and reagents for medical, veterinary and diagnostic testing in the nature of diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids, human tissue and animal tissue for use in disease detection; medical and veterinary diagnostic reagents and assays for testing of fluids |
| Goods and Services | Medical, veterinary and diagnostic services, namely, medical testing for diagnostic or treatment purposes, virus testing for medical diagnostic or treatment purposes, veterinary testing for diagnostic or treatment purposes; medical and veterinary testing services, namely, genetic testing for medical, diagnostic and treatment purposes, veterinary testing for diagnostic or treatment purposes; medical and veterinary testing for diagnostic or treatment purposes; medical and veterinary analysis services for diagnostic and treatment purposes, namely, medical analysis for the diagnosis and treatment of persons, medical analysis for the diagnosis and treatment of animals; medical and veterinary testing services relating to diagnosis and treatment; medical and veterinary analysis services, namely, medical analysis for the diagnosis and treatment of persons, medical analysis for the diagnosis and treatment of animals; information and advisory services in respect of the aforementioned services |
| Goods and Services | Research and development services in the field of medical diagnostics and medical testing; product design and development of diagnostic apparatus, instruments, equipment, tools and devices; product research, design and development in the field of diagnostic preparations; product research, design and development of reagents; product research, design and development of aptamer reagents; product research, design and development of aptamer reagents for integration into diagnostic platforms; product research, design and development of reagents for therapeutic applications; product research, design and development of aptamer reagents for therapeutic applications; custom product development of reagents; custom product development of aptamer reagents; medical research, namely, optimsation of aptamer molecules; product research, design and development of nucleic acids for medical, veterinary, diagnostic and pharmaceutical purposes; product research, design and development of nucleic acid sequences for medical, veterinary, diagnostic and pharmaceutical purposes laboratory testing services, namely, testing of pharmaceuticals; medical and scientific laboratory services for analytical testing; design and development of testing and analysis methods, namely, research and development of advanced learning technologies and teaching methods; medical and scientific laboratory services, namely, preparation of biological samples for testing and analysis in research laboratories; medical and veterinary research services; medical and veterinary laboratory services; scientific research and investigations for medical and veterinary purposes; medical and scientific laboratory services, namely, analysis of human and animal tissues and samples for medical and veterinary research; biological research, clinical research, medical research and veterinary research in the field of medical diagnostics and medical testing; provision of information and data relating to medical and veterinary research and development; information and advisory services in respect of the aforementioned services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 6, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 6, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 6, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Aptamer Group Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Aptamer Group Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Friday, May 13, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, May 5, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, May 6, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 6, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, May 10, 2022 | APPLICATION FILING RECEIPT MAILED |
| Saturday, May 14, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, June 14, 2022 | REFUSAL PROCESSED BY MPU |
| Wednesday, June 15, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, July 6, 2022 | REFUSAL PROCESSED BY IB |
| Thursday, December 15, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, December 15, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 16, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 19, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, December 19, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Monday, December 19, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, October 11, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, October 11, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Monday, August 5, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, August 7, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 21, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 10, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 10, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 31, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |